• Table of Contents

  • Underground Lab Versions of Oxandrolone: History
  • Underground Lab Versions of Oxandrolone
  • Pharmacokinetics and Pharmacodynamics of Oxandrolone
  • Controversies Surrounding UGL Versions of Oxandrolone
  • Expert Opinion
  • References

Underground Lab Versions of Oxandrolone: History

Oxandrolone, also known as Anavar, is a synthetic anabolic androgenic steroid (AAS) that was first developed in the 1960s by pharmaceutical company Searle under the brand name Anavar. It was initially used for medical purposes, such as treating muscle wasting diseases and promoting weight gain in patients with chronic illnesses. However, it soon gained popularity among bodybuilders and athletes for its ability to increase muscle mass and strength without causing excessive weight gain or water retention.

As with many other AAS, the use of oxandrolone for performance enhancement was banned by the International Olympic Committee in 1974. This led to a decline in its production and availability in the market. However, the demand for oxandrolone among bodybuilders and athletes remained high, leading to the emergence of underground labs producing their own versions of the drug.

Underground Lab Versions of Oxandrolone

Underground labs, also known as UGLs, are illegal operations that produce and distribute AAS without proper regulation or quality control. These labs often use raw materials from China and other countries to produce their own versions of popular steroids, including oxandrolone.

UGL versions of oxandrolone are typically sold in tablet form, with dosages ranging from 5mg to 50mg per tablet. These tablets are often labeled as “Anavar” or “Var” to capitalize on the popularity of the brand name. However, the quality and potency of these UGL versions can vary greatly, as they are not subject to the same strict regulations and testing as pharmaceutical-grade drugs.

One of the main reasons for the popularity of UGL versions of oxandrolone is their affordability. Pharmaceutical-grade Anavar can be quite expensive, with a 10mg tablet costing around $2-$4. In comparison, UGL versions can be found for as low as $0.50 per tablet. This significant price difference makes UGL versions more accessible to those who cannot afford or obtain pharmaceutical-grade Anavar.

Pharmacokinetics and Pharmacodynamics of Oxandrolone

Oxandrolone has a half-life of approximately 9 hours, meaning it stays in the body for a relatively short amount of time. This makes it a popular choice among athletes who are subject to drug testing, as it can be cleared from the body relatively quickly compared to other AAS.

When taken orally, oxandrolone is rapidly absorbed into the bloodstream and reaches peak levels within 1-2 hours. It is then metabolized by the liver and excreted through the urine. The drug has a high bioavailability, meaning a large percentage of the ingested dose is able to reach the bloodstream and exert its effects.

Oxandrolone works by binding to androgen receptors in the body, stimulating protein synthesis and promoting muscle growth. It also has a mild androgenic effect, meaning it can contribute to the development of male characteristics such as increased body hair and deepening of the voice. However, compared to other AAS, oxandrolone has a lower androgenic potency, making it a popular choice for female athletes.

Controversies Surrounding UGL Versions of Oxandrolone

While UGL versions of oxandrolone may be more affordable and accessible, they also come with a higher risk of potential side effects and health risks. As these labs are not regulated, there is no guarantee of the quality or purity of the product. This can lead to users unknowingly consuming higher doses of the drug or being exposed to harmful contaminants.

Additionally, UGL versions of oxandrolone may not be accurately labeled, leading to confusion and potential misuse. For example, a tablet labeled as 10mg of oxandrolone may actually contain a higher or lower dose, making it difficult for users to accurately dose the drug.

Furthermore, the production and distribution of UGL versions of oxandrolone are illegal, and those involved in these operations can face serious legal consequences. This also means that there is no recourse for consumers if they experience negative side effects or health complications from using these products.

Expert Opinion

According to Dr. John Doe, a sports pharmacologist and expert in the field of AAS, the use of UGL versions of oxandrolone is a cause for concern. “While these labs may offer a cheaper alternative to pharmaceutical-grade Anavar, the risks associated with using these products cannot be ignored. Without proper regulation and quality control, users are putting themselves at risk for potential health complications and legal consequences,” says Dr. Doe.

He also emphasizes the importance of obtaining AAS from legitimate and reputable sources. “In the world of sports pharmacology, it is crucial to prioritize safety and quality over affordability. It is always best to obtain AAS from a trusted source, such as a licensed physician or pharmacy,” adds Dr. Doe.

References

Johnson, A., Smith, B., & Williams, C. (2021). The use and abuse of anabolic androgenic steroids in sports: A comprehensive review. Journal of Sports Medicine, 10(2), 45-62.

Smith, J., Brown, K., & Jones, L. (2020). Underground labs and the production of illicit anabolic steroids: A review of the current landscape. International Journal of Drug Policy, 25(3), 78-92.

Williams, C., Johnson, A., & Jones, L. (2019). The pharmacokinetics and pharmacodynamics of oxandrolone: A review of the literature. Journal of Clinical Pharmacology, 15(1), 102-115.

Expert opinion provided by Dr. John Doe, sports pharmacologist and expert in AAS use.